NeoGenomics Laboratories
Fluorescence in Situ Hybridization Service
Fluorescence in situ hybridization (FISH) testing utilizes the combined strengths of traditional cytogenetics, DNA hybridization and fluorescent microscopy to identify sub-microscopic chromosomal structural rearrangements, variants, and low-frequency abnormalities beyond the limits of classic cytogenetic testing. Our full menu of FISH panels and tests provide physicians with flexible ordering options to aid in rapid and cost-effective characterization of hematologic diseases and solid tumors.
Most popular related searches
fluorescence in-situ hybridization
fluorescent in-situ hybridization
disease diagnosis
solid tumor
hematologic
lymphoma
hematology
disease risk
Highlights of Our FISH Program
- Offering a broad menu of over 75 FISH panels and tests
- NeoGenomics pioneered Technical-Only (TC) FISH testing services and have been partnering with Pathologists since the mid-2000s. >95% of panels and tests are available for tech-only ordering
- >95% of tests have a 4-5 day TAT, with a STAT (12-24hrs) result option available for select tests
- On-demand training and webinars are available on NeoUniversity™ for enhanced technical and clinical interpretation of results
HemeFISH
- Focused panels for hematologic disease diagnosis and risk stratification
- Examples: AML, ALL, NHL, MDS, MPN, and MM panels
- High-grade B-cell lymphoma FISH panel reflex option for a stepwise testing approach for diagnosis and classification of B-cell lymphomas
- Plasma cell enrichment performed automatically improves ability to diagnose MM/MGUS patients